APLM Stock: Apollomics, Inc. Stock Price, Analysis & Insights
Get live aplm stock price $20.96, comprehensive Apollomics, Inc. stock analysis, charts, news, and expert forecast. Real-time aplm stock data and investment insights.
Loading chart...
Company Overview
Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2015 and is based in Foster City, California.
Company Information
- CEO
- Guo-Liang Yu
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 13
Contact Information
- Address
- 989 East Hillsdale Blvd
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.81)
Business Model & Strategy
Apollomics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Guo-Liang Yu, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Apollomics, Inc. competes in the Biotechnology within the broader Healthcare. With 23.1 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Apollomics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Apollomics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Apollomics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Apollomics, Inc.
- ⚠Investors should consider how Apollomics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
23.13M
P/E Ratio
-0.40
Beta
1.81
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 23.13M market capitalization
- Trading Volume: 108.24K shares traded today
- Price Range: 52-week range of $3.66 - $42.12
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Apollomics, Inc.
Apollomics, Inc. (APLM) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 23.13M, the company represents a significant player in its market. The stock is currently trading at $20.96 with a positivedaily change of 26.88%.
The company's 13 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.40, beta of 1.81, and 52-week price range from $3.66 to $42.12when evaluating investment opportunities.
Why Invest in Apollomics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Guo-Liang Yu
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.